[an error occurred while processing the directive]
Michael Obermayer is the executive chairman of Troika Capital Partnersí New Growth Fund, a $300 mln private equity fund jointly sponsored by Troika Dialog and Singaporeís Temasek, and a partner and non-executive director at Troika Dialog. Obermayer is also a non-executive director at Pharmacy Chain 36.6 and an advisory board member at Moscow School of Management SKOLKOVO. He started his private sector career with McKinsey & Company in Copenhagen, eventually chairing the firmís East European operations from Prague and Moscow. Obermayer also spent two years as a managing director at the World Economic Forum in Geneva.
He has graduated from the University of Stockholm, The Royal Institute of Technology and Ludwig Maximilian University and holds a doctorate in biochemistry. He also earned an MBA from INSEAD, where he is an adjunct professor.[an error occurred while processing the directive]